AnalystsSteve BrozakSteve Brozak's Stock Forecasts
AnalystsSteve Brozak
Sectors:
Analyst Ranking
Bottom 7%
#4759 out of 5067 analysts
Average Return
-20.1%
Win Rate
19%3 out of 16
Risk vs Reward
Poor
Good
Steve Brozak's 5 best and worst ratings
Steve Brozak Analyst Color
Get additional color on Steve Brozak's coverage of popular stocks
Steve Brozak's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Omeros CorpOMER | 2 | Strong Buy | $45.00 | +357.78% | Reiterates | 2 days ago |
Cidara Therapeutics IncCDTX | 5 | Strong Buy | $199.00 | +95.06% | Maintains | 8 days ago |
Celularity IncCELU | 2 | Buy | $6.00 | +181.69% | Upgrades | a month ago |
Marker Therapeutics IncMRKR | 1 | Strong Buy | $12.50 | +1,113.59% | Reiterates | 7 months ago |
Contrafect CorpCFRXQ | 2 | Strong Buy | $560.00 | N/A | Upgrades | 3 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Strong Buy | $11.00 | N/A | Upgrades | 4 years ago |
Redhill Biopharma LtdRDHL | 2 | Buy | $16,000.00 | N/A | Downgrades | 4 years ago |
Cohbar IncCWBR | 1 | Buy | $135.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.